A five-grade imaging classification system and diagnostic therapeutic algorithm may reduce the risk for primary periphyseal ...
Asianet Newsable on MSN
Plus Therapeutics provides mid-year business update including corporate rebranding
Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026< Affirms 2026 guidance on key ...
OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced that Scott Thielman, PhD, PE, has joined the company as Vice President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results